Suitability of PER.C6 cells to generate epidemic and pandemic influenza vaccine strains by reverse genetics. (Q30376923)

21 June 2017

title

Suitability of PER.C6 cells to generate epidemic and pandemic influenza vaccine strains by reverse genetics. (English)

1 reference

21 June 2017

0 references

1 reference

W Barclay

14

0 references

author name string

W Koudstaal

1

1 reference

21 June 2017

L Hartgroves

2

1 reference

21 June 2017

M Havenga

3

1 reference

21 June 2017

I Legastelois

4

1 reference

21 June 2017

C Ophorst

5

1 reference

21 June 2017

M Sieuwerts

6

1 reference

21 June 2017

D Zuijdgeest

7

1 reference

21 June 2017

R Vogels

8

1 reference

21 June 2017

J Custers

9

1 reference

21 June 2017

E de Boer-Luijtze

10

1 reference

21 June 2017

O de Leeuw

11

1 reference

21 June 2017

L Cornelissen

12

1 reference

21 June 2017

J Goudsmit

13

1 reference

21 June 2017

language of work or name

English

0 references

publication date

20 February 2009

1 reference

21 June 2017

1 reference

21 June 2017

volume

27

1 reference

21 June 2017

issue

19

1 reference

21 June 2017

page(s)

2588-2593

1 reference

Responsiveness to a pandemic alert: use of reverse genetics for rapid development of influenza vaccines.

21 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.033

From lethal virus to life-saving vaccine: developing inactivated vaccines for pandemic influenza.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.033

Generation of influenza vaccine viruses on Vero cells by reverse genetics: an H5N1 candidate vaccine strain produced under a quality system.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.033

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.033

Generation of influenza A viruses entirely from cloned cDNAs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.033

Plasmid-only rescue of influenza A virus vaccine candidates.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.033

Eight-plasmid system for rapid generation of influenza virus vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.033

"Ambisense" approach for the generation of influenza A virus: vRNA and mRNA synthesis from one template

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.033

A DNA transfection system for generation of influenza A virus from eight plasmids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.033

Preparation of genetically engineered A/H5N1 and A/H7N1 pandemic vaccine viruses by reverse genetics in a mixture of Vero and chicken embryo cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.033

Evaluation of a genetically modified reassortant H5N1 influenza A virus vaccine candidate generated by plasmid-based reverse genetics.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.033

Generation of candidate human influenza vaccine strains in cell culture - rehearsing the European response to an H7N1 pandemic threat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.033

Establishment of canine RNA polymerase I-driven reverse genetics for influenza A virus: its application for H5N1 vaccine production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.033

An adenovirus vector-mediated reverse genetics system for influenza A virus generation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.033

An improved reverse genetics system for influenza A virus generation and its implications for vaccine production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.033

A reverse-genetics system for Influenza A virus using T7 RNA polymerase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.033

Cloning of the canine RNA polymerase I promoter and establishment of reverse genetics for influenza A and B in MDCK cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.033

The human cell line PER.C6 provides a new manufacturing system for the production of influenza vaccines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.033

Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.033

Changes in in vitro susceptibility of influenza A H3N2 viruses to a neuraminidase inhibitor drug during evolution in the human host

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.033

The M1 matrix protein controls the filamentous phenotype of influenza A virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.033

A reverse genetics approach for recovery of recombinant influenza B viruses entirely from cDNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.033

New helper cells and matched early region 1-deleted adenovirus vectors prevent generation of replication-competent adenoviruses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.033

An improved single-radial-immunodiffusion technique for the assay of influenza haemagglutinin antigen: Application for potency determinations of inactivated whole virus and subunit vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.033

Reference viruses for seasonal and pandemic influenza vaccine preparation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.02.033

10.1016/J.VACCINE.2009.02.033

7 January 2021

Identifiers

DOI

1 reference

21 June 2017

1 reference